Cargando…
Reply to Kratz et al.
Autores principales: | Frebourg, Thierry, Lagercrantz, Svetlana Bajalica, Oliveira, Carla, Magenheim, Rita, Evans, D. Gareth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576774/ https://www.ncbi.nlm.nih.gov/pubmed/32792624 http://dx.doi.org/10.1038/s41431-020-00710-y |
Ejemplares similares
-
Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes
por: Frebourg, Thierry, et al.
Publicado: (2020) -
Germline TP53 Testing in Breast Cancers: Why, When and How?
por: Evans, D. Gareth, et al.
Publicado: (2020) -
Comment on “The translational challenge in Chagas disease drug development” by Kratz et al.
por: De Rycker, Manu
Publicado: (2022) -
Reply to Turnbull et al. and to Hulme et al.
por: Breuer, Oded, et al.
Publicado: (2020) -
Reply to Gueret et al. and to Hammond et al.
por: Brown, Ryan M., et al.
Publicado: (2020)